CEACAM5 and colorectal carcinoma: Dixon et al. have demonstrated that patients with high CEA and low albumin levels likely reflect some type of systemic compromise from an activation of a metabolically active tumor, exhibiting a significantly decreased survival time in CRC patients [5].